MAP1LC3A and liver cancer: Moreover, ectopic TIPRL promoted expressions of LC3 and CD133 as well as viability of HCC/liver cancer cell-lines, which were reduced in siTIPRL/siCD133-cells (Supplementary Fig. 2e–j).